COMP and Hepatic fibrosis: The ROC curve analysis unveiled that circulating COMP could be employed as a useful biomarker for monitoring unfavorable outcome of BA patients following KPE, which has been attested by a recent study conducted by Zachou et al.18 denoting serum COMP as a novel non-invasive biomarker for liver fibrosis in patients with HCV infection.